Efficacy and safety of tolvaptan for refractory fluid collection and edema in the terminal cancer patients
{{output}}
Objective: Tolvaptan, a vasopressin V2 receptor antagonist, is an oral diuretic. Patients with terminal cancer develop marked fluid retention, and oral diuretics other than tolvaptan have been used as treatments without clear the... ...
